In This Section      
Print This Page

Thyroid Cancer

Thyroid cancer, which is more common in women than in men, is treated by expert teams within our thyroid tumor centers that include endocrinologists, surgeons, pathologists, medical oncologists and radiation oncologists who evaluate each person's cancer and incorporate the latest knowledge and pioneering technology in their treatment plans.

Johns Hopkins experts have moved the field forward with their innovations in detecting thyroid cancer, pioneering new treatments for the disease working with patients who have inherited forms of it. Johns Hopkins was the first hospital to offer transoral robotic thyroid surgery, and is one of only a few centers in the US to offer scarless thyroidectomy and parathyroidectomy.

Most types of thyroid cancer have a good prognosis and, for more advanced cancers, seeking expert care at Johns Hopkins offers access to clinical trials that may eventually set new standards of care.

Thyroid Cancer: What You Need to Know

Father and Son on Laptop
  • Thyroid cancer represented 3.8% of all new cancer cases in the United States. 
  • There are an estimated 64,300 new cases of thyroid cancer in 2016. 
  • Thyroid cancer is most frequently diagnosed among people 45-54 years of age. 
  • Approximately 1.1 percent of men and women will be diagosed with thyroid cancer at some point during their lifetime. 

Patient Resources

Thyroid and Parathyroid Conditions FAQ's

Johns Hopkins head, neck, thyroid surgeon, Ralph Tufano, answers commonly asked questions about the treatment of thyroid tumors and how Johns Hopkins multidisciplinary team treats and diagnoses thyroid tumors and nodules.

 
 

Chemo School & Virtual Tour

Take our video class to learn about your first steps in receiving chemotherapy Chemo School
Prepare for your first visit with this "walking" tour of our clinical facilities.  Watch the video.

Read Our Blogs

Cancer Matters timely topics
Our Cancer for caregivers

The Kimmel Wire

Latest News from the Kimmel Cancer Center
Subscribe Now